T. Bochenek

Publications65
h-index14
Citations560
Highly Influential Citations18
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • B. Godman
  • 367 Publications • 5,637 Citations
  • S. Simoens
  • 438 Publications • 7,486 Citations
  • Vanda Marković-Peković
  • 32 Publications • 670 Citations
  • B. Wettermark
  • 231 Publications • 5,776 Citations
  • Publications
  • Influence
Poland: Health System Review.
This analysis of the Polish health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. In late… Expand
  • 18
  • 3
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
BackgroundManaged entry agreements (MEAs) are a set of instruments to facilitate access to new medicines. This study surveyed the implementation of MEAs in Central and Eastern Europe (CEE) where… Expand
  • 58
  • 2
  • PDF
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries
Drug shortages have been identified as a public health problem in an increasing number of countries. This can negatively impact on the quality and efficiency of patient care, as well as contribute to… Expand
  • 36
  • 2
  • PDF
Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA
ABSTRACT Introduction: In January 2018 the European Commission published a Proposal for a Regulation on Health Technology Assessment (HTA): ‘Proposal for a Regulation on health technology assessment… Expand
  • 13
  • 2
The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland
ABSTRACT Background: The appropriate access to public information is very important for healthcare system stakeholders. The goal of this study was to examine how the execution of the formally… Expand
  • 7
  • 2
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation
Medicines receiving a conditional marketing authorization through Medicines Adaptive Pathways to Patients (MAPPs) will be a challenge for payers. The “introduction” of MAPPs is already seen by the… Expand
  • 31
  • 1
  • PDF
A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives
The problem of drug shortages has been reported worldwide, gaining prominence in multiple domains and several countries in recent years. The aim of the study was to analyze, characterise and assess… Expand
  • 36
  • 1
  • PDF
Medicine Shortages: Gaps Between Countries and Global Perspectives
Introduction: Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been… Expand
  • 20
  • 1
  • PDF
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Background The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and… Expand
  • 18
  • 1
Initiatives to increase the prescribing of low cost generics: the case of Scotland in the international context
Getting the most out of the pharmaceutical budget is critical across all countries as the financial pressures on healthcare systems intensify. In this paper, we review global practice on encouraging… Expand
  • 18
  • 1
...
1
2
3
4
5
...